Association between the polymorphism rs3217927 of ccnd2 and the risk of childhood acute lymphoblastic leukemia in a chinese population

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zhang, Heng ^a   Zhou, Yan ^a   Rui, Yaoyao ^a   Wang, Yaping ^a   Li, Jie ^b   Rong, Liuchen ^a   Wang, Meilin ^c   Tong, Na ^c   Zhang, Zhengdong ^c   Chen, Jing ^d   Fang, Yongjun ^a  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CCND2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CCND2 GENE; CHILD; CHILDHOOD LEUKEMIA; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRESCHOOL CHILD; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CLINICAL TRIAL; EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; INFANT; MULTICENTER STUDY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; CYCLIN D2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MALE; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 84899678956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095059     Document Type: Article

References (40)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Kaatsch P (2010) Epidemiology of childhood cancer. Cancer Treat Rev 36: 277-285.
3. Terracini B (2011) Epidemiology of childhood cancer. Environ Health 10 Suppl 1: S8.
4. Armstrong SA, Look AT (2005) Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 23: 6306-6315.
5. Pui CH (2009) Acute lymphoblastic leukemia: introduction. Semin Hematol 46: 1-2.
6. Mrozek K, Harper DP, Aplan PD (2009) Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am 23: 991-1010, v.
7. Sicinska E, Aifantis I, Le Cam L, Swat W, Borowski C, et al. (2003) Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 4: 451-461.
8. Buchakjian MR, Kornbluth S (2010) The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol 11: 715-727.
9. Siebert R, Willers CP, Opalka B (1996) Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma. Leuk Lymphoma 23: 505-520.
10. Katoh Y, Katoh M (2005) Hedgehog signaling pathway and gastric cancer. Cancer Biol Ther 4: 1050-1054.
11. Katoh Y, Katoh M (2009) Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. Int J Oncol 35: 187-192.
12. Han Y, Xia G, Tsang BK (2013) Regulation of cyclin D2 expression and degradation by follicle-stimulating hormone during rat granulosa cell proliferation in vitro. Biol Reprod 88: 57
13. Chiles TC (2004) Regulation and function of cyclin D2 in B lymphocyte subsets. J Immunol 173: 2901-2907.
14. Ohtsubo M, Roberts JM (1993) Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259: 1908-1912.
15. Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA (2007) Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3: e42.
16. Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, et al. (2008) Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 29: 333-341.
17. Chang BL, Zheng SL, Isaacs SD, Wiley KE, Turner A, et al. (2004) A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer. Cancer Res 64: 1997-1999.
18. Hosgood HD 3rd, Menashe I, Shen M, Yeager M, Yuenger J, et al. (2008) Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 29: 1938-1943.
19. Ye Y, Yang H, Grossman HB, Dinney C,Wu X, et al. (2008) Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer 112: 2467-2474.
20. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, et al. (2006) Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 78: 464-479.
21. Huang M, Spitz MR, Gu J, Lee JJ, Lin J, et al. (2006) Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis 27: 2034-2037.
22. Jia WH, Zhang B, Matsuo K, Shin A, Xiang YB, et al. (2013) Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet 45: 191-196.
23. Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, et al. (2013) Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology 144: 799-807 e724.
24. Whyatt RM, Perera FP (1995) Application of biologic markers to studies of environmental risks in children and the developing fetus. Environ Health Perspect 103 Suppl 6: 105-110.
25. Perera FP (1997) Environment and cancer: who are susceptible? Science 278: 1068-1073.
26. Ely S, Di Liberto M, Niesvizky R, Baughn LB, Cho HJ, et al. (2005) Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/ cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. Cancer Res 65: 11345-11353.
27. Sherr CJ (2000) The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 60: 3689-3695.
28. Delmer A, Ajchenbaum-Cymbalista F, Tang R, Ramond S, Faussat AM, et al. (1995) Overexpression of cyclin D2 in chronic B-cell malignancies. Blood 85: 2870-2876.
29. Akagi T, Ono H, Shimotohno K (1996) Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1. Oncogene 12: 1645-1652.
30. Clappier E, Cuccuini W, Cayuela JM, Vecchione D, Baruchel A, et al. (2006) Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia 20: 82-86.
31. Karrman K, Andersson A, Bjorgvinsdottir H, Strombeck B, Lassen C, et al. (2006) Deregulation of cyclin D2 by juxtaposition with T-cell receptor alpha/ delta locus in t(12;14)(p13;q11)-positive childhood T-cell acute lymphoblastic leukemia. Eur J Haematol 77: 27-34.
32. Mao X, Liang SB, Hurren R, Gronda M, Chow S, et al. (2008) Cyproheptadine displays preclinical activity in myeloma and leukemia. Blood 112: 760-769.
33. Song H, Hogdall E, Ramus SJ, Dicioccio RA, Hogdall C, et al. (2008) Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res 14: 1090-1095.
34. Ma H, Chen J, Pan S, Dai J, Jin G, et al. (2011) Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Lung Cancer 73: 32-37.
35. Yang JJ, Cheng C, Yang W, Pei D, Cao X, et al. (2009) Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA 301: 393-403.
36. Trevino LR, Yang W, French D, Hunger SP, Carroll WL, et al. (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41: 1001-1005.
37. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, et al. (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41: 1006-1010.
38. Orsi L, Rudant J, Bonaventure A, Goujon-Bellec S, Corda E, et al. (2012) Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 26: 2561-2564.
39. Medina PP, Slack FJ (2008) microRNAs and cancer: an overview. Cell Cycle 7: 2485-2492.
40. Cai Y, Yu X, Hu S, Yu J (2009) A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics 7: 147-154.